TRIPLE SULFA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triple Sulfa, and what generic alternatives are available?
Triple Sulfa is a drug marketed by Alpharma Us Pharms, Fougera, Padagis Us, Purepac Pharm, Pharmaderm, and Lederle. and is included in eight NDAs.
The generic ingredient in TRIPLE SULFA is trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine). Additional details are available on the trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIPLE SULFA?
- What are the global sales for TRIPLE SULFA?
- What is Average Wholesale Price for TRIPLE SULFA?
Summary for TRIPLE SULFA
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 95 |
| DailyMed Link: | TRIPLE SULFA at DailyMed |
US Patents and Regulatory Information for TRIPLE SULFA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | TRIPLE SULFA | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) | CREAM;VAGINAL | 087864-001 | Sep 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmaderm | TRIPLE SULFA | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) | TABLET;VAGINAL | 088462-001 | Jan 3, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | TRIPLE SULFA | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) | SUSPENSION;ORAL | 080280-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
